← Leaderboards
Suhn Kyong Rhie
University Of Southern California
$2,061,518
Attributed
$2,061,518
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $784.8K · FY2018–23$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,061,518 · 4
By mechanism
R21$1,424,066 · 3
K01$637,452 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Benjamin P Berman$2,108,710
- Ya-Wen Chen$3,420,582
- Christopher Alan Haiman$47,382,319
- Simon Andrew Gayther$9,015,265
- Paul Pharoah$1,833,190
Others in their field
Other Emerging Leaders on “Chromatin Immunoprecipitation”
- Michael-Christopher Keogh · Epicypher, Inc.$6,820,819
- Bryan J Venters · Epicypher, Inc.$6,693,077
- Eric Mendenhall · Hudson-Alpha Institute For Biotechnology$5,068,426
- Anthony Schmitt · Arima Genomics, Inc.$4,157,145
- Daniel A Jacobson · Research Triangle Institute$3,065,614
- Maya Capelson · University Of Pennsylvania$2,992,628
Research focus
Chromatin ImmunoprecipitationTranscriptome SequencingEpigenetic ProcessMolecularChip-SeqGene ExpressionMalignant Neoplasm Of ProstateMalignant NeoplasmsResearch PersonnelRegulatory ElementData SetGenome-WideThe Cancer Genome AtlasGenesMapsGene Expression RegulationInsightHuman DiseaseDna MethylationBehaviorEnhancersLeadGenetic TranscriptionCarcinogenesis
Grant awards (9)
Identifying epigenetic states of TADs and targeting using epigenome editing$206,250
R21 · FY2023 · HG · contact PI
Mapping regulatory elements and chromatin structures in prostate tumor subtypes at single nucleosome resolution$226,784
R21 · FY2022 · CA · contact PI
Identifying epigenetic states of TADs and targeting using epigenome editing$206,250
R21 · FY2022 · HG · contact PI
Reversing molecular cancer phenotypes by targeting epigenetic alterations in prostate cancer$385,688
R21 · FY2021 · CA · contact PI
Identifying epigenetic states of TADs and targeting using epigenome editing$206,250
R21 · FY2021 · HG · contact PI
Mapping regulatory elements and chromatin structures in prostate tumor subtypes at single nucleosome resolution$192,844
R21 · FY2021 · CA · contact PI
Identification and Clinical Validation of Key Transcription Factor Isoforms Linked to Breast and Prostate Cancer Subgroups using Epigenetic Traits$235,174
K01 · FY2020 · CA · contact PI
Identification and Clinical Validation of Key Transcription Factor Isoforms Linked to Breast and Prostate Cancer Subgroups using Epigenetic Traits$233,215
K01 · FY2019 · CA · contact PI
Identification and Clinical Validation of Key Transcription Factor Isoforms Linked to Breast and Prostate Cancer Subgroups using Epigenetic Traits$169,063
K01 · FY2018 · CA · contact PI